Related Experiment Video
Updated: Aug 13, 2026

11:42
Combination of Microstereolithography and Electrospinning to Produce Membranes Equipped with Niches for Corneal Regeneration
Published on: September 12, 2014
13.0K
Bioactive self-assembled peptide nanofibers for corneal stroma regeneration
G Uzunalli1, Z Soran1, T S Erkal1
1Institute of Materials Science and Nanotechnology, National Nanotechnology Research Center (UNAM), Bilkent University, Ankara 06800, Turkey.
Acta Biomaterialia
|December 17, 2013
Summary
This study presents a novel peptide nanofiber scaffold for corneal stroma regeneration. Laminin-mimetic nanofibers show promise for enhancing keratocyte function and healing damaged corneas.
Area of Science:
- Biomaterials Science
- Ophthalmology
- Regenerative Medicine
Background:
- Corneal stroma defects from trauma or disease impair vision.
- Effective corneal regeneration therapies are crucial.
- Existing treatments have limitations.
Purpose of the Study:
- To develop and evaluate a bioactive peptide nanofiber scaffold for corneal stroma regeneration.
- To investigate the potential of laminin- and fibronectin-mimetic nanofibers.
- To assess the scaffold's efficacy in a rabbit corneal injury model.
Main Methods:
- Self-assembling peptide amphiphiles with laminin and fibronectin sequences were synthesized.
- Human corneal keratocyte cells were cultured on the peptide nanofibers.
- The in vitro and in vivo effects on cell behavior and corneal regeneration were analyzed.
- Rabbit corneas with induced defects were treated with the laminin-mimetic nanofibers.
Main Results:
- Laminin-mimetic peptide nanofibers supported human corneal keratocyte morphology and proliferation.
- Cells on laminin-mimetic nanofibers showed enhanced proliferation compared to fibronectin-mimetic nanofibers.
- In vivo, laminin-mimetic nanofibers promoted keratocyte migration and corneal stroma regeneration in rabbits.
Conclusions:
- Laminin-mimetic peptide nanofibers serve as a promising synthetic scaffold for corneal regeneration.
- The injectable nature of the scaffold offers a potential therapeutic advantage.
- This system holds potential for treating corneal stromal defects.

